JOINT FILING AGREEMENTJoint Filing Agreement • July 3rd, 2023 • Bios Equity Partners, LP • Pharmaceutical preparations
Contract Type FiledJuly 3rd, 2023 Company IndustryIn accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Stock of Azitra Inc. and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13D.
June 10, 2020Transfer of Securities Agreement • June 23rd, 2020 • Bios Equity Partners, LP • Pharmaceutical preparations
Contract Type FiledJune 23rd, 2020 Company IndustryThis letter agreement (this “Agreement”) serves to confirm the agreement by and between Leslie W. Kreis, Jr., an individual resident of the State of Texas (“Kreis”), and BP Directors, LP, a Delaware limited partnership (“BP Directors”), regarding stock options and other awards of equity-based compensation granted to Kreis in his capacity as a director of Lantern Pharma Inc., a Delaware corporation (“Lantern”). As a director of Lantern, Kreis may receive stock options and other awards of equity-based compensation pursuant to the equity incentive plans that Lantern may have from time to time, including Lantern’s Amended and Restated 2018 Equity Incentive Plan, as amended (the “2018 Plan”). In consideration of the foregoing, the mutual covenants and agreements contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged:
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)Joint Filing Agreement • June 23rd, 2020 • Bios Equity Partners, LP • Pharmaceutical preparations
Contract Type FiledJune 23rd, 2020 Company IndustryThe undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.